Boundless Bio, a clinical-stage oncology company, announced its financial results for the first quarter of 2025, highlighting its ongoing commitments to developing innovative therapies for patients ...
Enrollment ongoing in BBI-355 / BBI-825 combination arm of the POTENTIATE trial Investigational new drug submission for BBI-940 on track, with a first-in-human clinical trial expected to initiate in ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Lisa Stiffler on Oct 3, 2025 at 3:15 ...
Boundless, the decentralized zero-knowledge (ZK) compute marketplace powered by RISC Zero, has launched its incentivized testnet (which it is calling “Mainnet Beta”) on Base. With Boundless’ ...
Just when it seemed like the biotech IPOs were being lulled back to sleep, Boundless Bio says it plans to hit Wall Street. The Arch-, Bayer- and RA-backed company filed an S-1 Wednesday afternoon, ...
ORLANDO, Fla.--(BUSINESS WIRE)--Boundless Learning™, a pioneer in digital learning solutions, today announced that Joshua Richards has been appointed CEO, effective immediately. Mr. Richards succeeds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results